Company · CIK 0001534248
Chemomab Therapeutics Ltd.
CMMBSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$1.16+$0.07 (+6.42%)
CMMB · Last trade
- Prev close
- $1.09
- Range (30d)
- $1.00 – $1.43
On the record
Recent filings
- 6-KCMMBForeign company update0001178913-26-004796 · 207.2 KBSEC(opens sec.gov)
- 6-KCMMBForeign company update0001178913-26-004676 · 56.0 KBSEC(opens sec.gov)
- SCHEDULE 13D/ACMMBChemomab Therapeutics Ltd.0001104659-26-106301 · 8.3 KBSEC(opens sec.gov)
- 6-KCMMBForeign company update0001178913-26-004193 · 3.4 MBSEC(opens sec.gov)
- SCHEDULE 13GCMMBChemomab Therapeutics Ltd.0002148623-26-000001 · 7.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/ACMMBChemomab Therapeutics Ltd.0001995601-26-000004 · 6.3 KBSEC(opens sec.gov)
- 6-KCMMBForeign company update0001178913-26-003442 · 809.6 KBSEC(opens sec.gov)
- 6-KCMMBForeign company update0001178913-26-003058 · 12.9 KBSEC(opens sec.gov)
- 6-KCMMBForeign company update0001178913-26-002672 · 264.9 KBSEC(opens sec.gov)
- 6-KCMMBForeign company update0001178913-26-002423 · 11.0 KBSEC(opens sec.gov)
Insiders
- Access Industries Holdings LLC10% Owner
- ACCESS INDUSTRIES, LLCAffiliate of 10% Owner
- ACCESS INDUSTRIES MANAGEMENT, LLCAffiliate of 10% Owner
- Aharon ArnonChief Medical Officer
- Alon RuthDirector
- Blavatnik LenAffiliate of 10% Owner
- Burgin JonathanSee Remarks
- Cohen Neil HarrisDirector
- Daly Sean TVP, Clinical Operations
- Darvish NissimDirector
Tickers
Addresses
business
KIRYAT ATIDIM, BUILDING 7
TEL AVIV
mailing
KIRYAT ATIDIM, BUILDING 7
TEL AVIV
Former names
- Anchiano Therapeutics Ltd.2021-03-17
- BioCancell Ltd.2015-11-03
Same industry